| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@yongstandards.com |
| Products Intro: |
Product Name:Folic Acid Impurity 13 Calcium Salt
CAS:133978-75-3
Purity:99%+ HPLC Package:10mg;25mg;50mg;100mg
|
Folitixorin Calcium manufacturers
- Folitixorin calcium
-
- $3500.00 / 25mg
-
2026-01-05
- CAS:133978-75-3
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Folitixorin Calcium Basic information |
| Product Name: | Folitixorin Calcium | | Synonyms: | Folitixorin Calcium;Folic Acid Impurity 13 Calcium Salt;Folic Acid Impurity 13 Calcium Salt (Calcium Levofolinate EP Impurity I Calcium Salt) | | CAS: | 133978-75-3 | | MF: | C20H25CaN7O6 | | MW: | 499.54 | | EINECS: | | | Product Categories: | | | Mol File: | 133978-75-3.mol |  |
| | Folitixorin Calcium Chemical Properties |
| | Folitixorin Calcium Usage And Synthesis |
| Uses | Folitixorin calcium is a cofactor and an analog of leucovorin. Folitixorin calcium is a promising agent for modulation of 5-FU cytotoxicity in adjuvant cancer research[1][2]. | | References | [1] Costantini CL, et al. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer. Hepatogastroenterology. 2009;56(91-92):645-649. PMID:19621672
[2] Carlsson G, et al. 5-fluorouracil (5-FU) and 5,10-methylene tetrahydrofolate (5,10-CH2FH4) as adjuvant therapy in an experimental rodent colon carcinoma model. Anticancer Res. 1997;17(5A):3671-3674. PMID:9413221
[3] Botto LD, et al. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862-877. DOI:10.1093/oxfordjournals.aje.a010290 |
| | Folitixorin Calcium Preparation Products And Raw materials |
|